Jixue Wang

671 total citations
23 papers, 536 citations indexed

About

Jixue Wang is a scholar working on Biomedical Engineering, Biomaterials and Surgery. According to data from OpenAlex, Jixue Wang has authored 23 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 9 papers in Biomaterials and 6 papers in Surgery. Recurrent topics in Jixue Wang's work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Jixue Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Jixue Wang collaborates with scholars based in China, United States and Australia. Jixue Wang's co-authors include Shengxian Li, Jianxun Ding, Chunxi Wang, Chunxi Wang, Xiaoqing Wang, Jingjing Guan, Xuesi Chen, Di Li, Weiguo Xu and Liang He and has published in prestigious journals such as Advanced Functional Materials, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Jixue Wang

21 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jixue Wang China 12 277 259 142 97 71 23 536
Chunxi Wang China 13 270 1.0× 270 1.0× 169 1.2× 93 1.0× 50 0.7× 18 565
Myeong Ju Moon South Korea 12 245 0.9× 300 1.2× 157 1.1× 71 0.7× 62 0.9× 18 618
Tian-Lu Cheng Taiwan 8 238 0.9× 156 0.6× 280 2.0× 97 1.0× 59 0.8× 10 602
Lili Ma China 13 354 1.3× 287 1.1× 188 1.3× 93 1.0× 38 0.5× 24 690
Jianati Dawulieti China 10 168 0.6× 239 0.9× 281 2.0× 166 1.7× 50 0.7× 11 731
Flavio Dormont France 6 414 1.5× 252 1.0× 304 2.1× 65 0.7× 60 0.8× 10 757
Matthieu Germain France 9 227 0.8× 262 1.0× 195 1.4× 51 0.5× 59 0.8× 15 567
Xiuqi Liang China 14 132 0.5× 284 1.1× 201 1.4× 175 1.8× 56 0.8× 20 545
Manse Kim South Korea 11 163 0.6× 276 1.1× 133 0.9× 70 0.7× 76 1.1× 12 520

Countries citing papers authored by Jixue Wang

Since Specialization
Citations

This map shows the geographic impact of Jixue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jixue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jixue Wang more than expected).

Fields of papers citing papers by Jixue Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jixue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jixue Wang. The network helps show where Jixue Wang may publish in the future.

Co-authorship network of co-authors of Jixue Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jixue Wang. A scholar is included among the top collaborators of Jixue Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jixue Wang. Jixue Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Min, Liang He, Chunxi Wang, Ji Lu, & Jixue Wang. (2025). Biomimetic LHRH-functionalized erythrocyte-camouflaged nanogels for targeted therapy of prostate cancer. Colloids and Surfaces B Biointerfaces. 257. 115088–115088.
2.
He, Liang, Liang Hao, Jixue Wang, et al.. (2025). Multifunctional nanoplatform as nano-inducer of ferroptosis for targeted recognition and imaging-guided therapy of metastatic prostate cancer. Materials Today Bio. 35. 102317–102317.
3.
Bu, Fan, Wenjun Wang, Rong Li, et al.. (2024). Research progress of ectopic thyroid cancer in thyroglossal duct cyst: A case report and literature review. Medicine. 103(26). e38540–e38540. 1 indexed citations
4.
Tan, Ming, et al.. (2024). Selective removal of chromium and chloride by flow electrode capacitive deionization (FCDI) with carrier-facilitated ion exchange membrane. Chemical Engineering Journal. 499. 156182–156182. 6 indexed citations
5.
Yang, Zhan, et al.. (2023). Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis. Frontiers in Pharmacology. 14. 1148021–1148021. 8 indexed citations
7.
Zheng, Chao, et al.. (2023). Comparation of intraureteral stent and conventional stent at different stages: a systematic review with meta-analysis. Minerva Urology and Nephrology. 75(6). 696–710. 1 indexed citations
8.
Shan, Hongli, et al.. (2020). Advances in Drug Delivery via Biodegradable Ureteral Stent for the Treatment of Upper Tract Urothelial Carcinoma. Frontiers in Pharmacology. 11. 224–224. 8 indexed citations
9.
Li, Shengxian, Jianhua Liu, Mengyao Sun, et al.. (2020). Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic. Frontiers in Pharmacology. 11. 24–24. 43 indexed citations
10.
Li, Shengxian, Xiangru Feng, Jixue Wang, et al.. (2019). Multiantigenic Nanoformulations Activate Anticancer Immunity Depending on Size. Advanced Functional Materials. 29(49). 57 indexed citations
11.
Wang, Jixue, Shengxian Li, Yuping Han, et al.. (2018). Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy. Frontiers in Pharmacology. 9. 202–202. 114 indexed citations
12.
Guo, Hui, Jixue Wang, Liang He, Yuchuan Hou, & Jianxun Ding. (2018). Targeting polyion complex micelle intracellularly delivers protein drug toward orthotopic bladder cancer. Nanomedicine Nanotechnology Biology and Medicine. 14(5). 1883–1883. 2 indexed citations
13.
Wang, Jixue, Weiguo Xu, Shengxian Li, et al.. (2018). Polylactide-Cholesterol Stereocomplex Micelle Encapsulating Chemotherapeutic Agent for Improved Antitumor Efficacy and Safety. Journal of Biomedical Nanotechnology. 14(12). 2102–2113. 47 indexed citations
14.
Wang, Jixue, Guanyu Wang, Hongli Shan, et al.. (2018). Gradiently degraded electrospun polyester scaffolds with cytostatic for urothelial carcinoma therapy. Biomaterials Science. 7(3). 963–974. 26 indexed citations
15.
Li, Shengxian, Xiangru Feng, Jixue Wang, et al.. (2018). Polymer nanoparticles as adjuvants in cancer immunotherapy. Nano Research. 11(11). 5769–5786. 72 indexed citations
16.
Guo, Hui, Weiguo Xu, Jixue Wang, et al.. (2017). Engineered nanogel with superior tissue affinity and cell targeting toward orthotopic bladder cancer. Journal of Controlled Release. 259. e48–e49. 1 indexed citations
17.
He, Liang, Di Li, Zhongtang Wang, et al.. (2016). l-Cystine-Crosslinked Polypeptide Nanogel as a Reduction-Responsive Excipient for Prostate Cancer Chemotherapy. Polymers. 8(2). 36–36. 24 indexed citations
18.
Wang, Jixue, Kexin Shen, Weiguo Xu, et al.. (2015). Stereocomplex micelle from nonlinear enantiomeric copolymers efficiently transports antineoplastic drug. Nanoscale Research Letters. 10(1). 907–907. 17 indexed citations
19.
Wang, Xiaoqing, Hongli Shan, Jixue Wang, et al.. (2015). Characterization of nanostructured ureteral stent with gradient degradation in a porcine model. International Journal of Nanomedicine. 10. 3055–3055. 37 indexed citations
20.
Wang, Jixue, Weiguo Xu, Hui Guo, et al.. (2015). Selective intracellular drug delivery from pH-responsive polyion complex micelle for enhanced malignancy suppression in vivo. Colloids and Surfaces B Biointerfaces. 135. 283–290. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026